Ceramide--antiestrogen nanoliposomal combinations--novel impact of hormonal therapy in hormone-insensitive breast cancer.
about
A review of ceramide analogs as potential anticancer agentsTamoxifen regulation of sphingolipid metabolism--Therapeutic implicationsRole of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer.Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemiaModification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.Synthesis and antiproliferative properties of a new ceramide analog of varacin.Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53.3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells.Lipid-based nanocarriers for breast cancer treatment - comprehensive review.Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents.Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer.Ceramide-containing liposomes with doxorubicin: time and cell-dependent effect of C6 and C12 ceramide.Sphingolipid metabolism in cancer signalling and therapy.
P2860
Q27009351-82A99F1D-D0C7-468C-A312-13E5C05CD500Q28084270-13633B67-2424-4BFE-9B47-11E10307CFE5Q30274798-AC83AE21-3E71-43E9-B971-317EF09C4180Q30276873-3C12FAB3-6ABC-4C97-A60A-95595CF39432Q30300370-9F2DFDD5-6B7A-48FF-84BF-F02311285425Q36479447-3E186150-92CA-4559-8C19-F1454DABD337Q36704209-D9765D23-5B99-4892-9262-2174995C2773Q38539202-1EB02E60-1F55-4983-BE92-AC738F9A2ACFQ38597794-2CAC0234-9AB8-4849-BF67-54AF3AEA4D84Q38831997-211187E6-EF7A-474B-B83D-3753144E32BCQ39097201-C199AA75-4C6B-4BEF-858E-E0B39A6619EEQ41135883-EAFB86D2-7A4E-46FB-8210-3EAB337DFF40Q46269345-B2F60B89-7EB9-4CF4-A73E-E6FB0F7C59B8Q49950035-1FB58DC0-95EC-4B26-A337-7C5A557F9B6F
P2860
Ceramide--antiestrogen nanoliposomal combinations--novel impact of hormonal therapy in hormone-insensitive breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Ceramide--antiestrogen nanolip ...... one-insensitive breast cancer.
@ast
Ceramide--antiestrogen nanolip ...... one-insensitive breast cancer.
@en
type
label
Ceramide--antiestrogen nanolip ...... one-insensitive breast cancer.
@ast
Ceramide--antiestrogen nanolip ...... one-insensitive breast cancer.
@en
prefLabel
Ceramide--antiestrogen nanolip ...... one-insensitive breast cancer.
@ast
Ceramide--antiestrogen nanolip ...... one-insensitive breast cancer.
@en
P2093
P2860
P1476
Ceramide--antiestrogen nanolip ...... one-insensitive breast cancer.
@en
P2093
Carmen Bedia
Gemma Fabrias
Jonathan C Levin
Myles C Cabot
Samy A F Morad
Sriram S Shanmugavelandy
P2860
P304
P356
10.1158/1535-7163.MCT-12-0594
P50
P577
2012-09-07T00:00:00Z